轉移乳癌或晚期乳癌以每週使用 docetaxel或paclitaxel治療的效果
Weekly Administration of Docetaxel and Paclitaxel in Metastatic or Advanced Breast Cancer
The Oncologist, Vol. 10, No. 9, 665-685, October 2005
...繼續閱讀

Temsirolimus用於局部晚期或轉移乳癌的第二期臨床試驗
Clinical Breast Camcer Vol. 6, No.3, Aug. 2005, pp 192-193
...繼續閱讀

Lapatinib用於HER2過度表現之晚期或轉移乳癌的治療
Clinical Breast Camcer Vol. 6, No.3, Aug. 2005, pp 191-192
...繼續閱讀

Reduced dose capecitabine is an effective and well-tolerated treatment in patients with metastatic breast cancer
減低劑量的截瘤達治療對於轉移乳癌病人是有效而耐受程度良好的治療
The Breast
Volume 14, Issue 5 , October 2005, Pages 368-374
...繼續閱讀

荷爾蒙受體狀態並不會影響轉移乳癌病人使用賀癌平治療的效果。
Hormone Rececptor Status Does Not Affect the Clinical Benefit of Trastuzumab Therapy for Patients with Metastatic Breast Cancer

Clinical Breast Cancer, Vol 6, No.3, 247-252, 2005
...繼續閱讀

Bendamustine 可以延緩轉移乳癌病人病情之惡化
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC
Anti-Cancer Drugs 2005, 16;871-877
...繼續閱讀

乳癌病人的腦部轉移
Brain Metastases in Patients with Breast Cancer: New Horizons
Clinical Breast Cancer, Vol.6, No. 2, 115-124, 2005
...繼續閱讀

高劑量mitoxantrone-vinblastine-cyclophosphamide 化學治療與自體血液幹細胞移植治療對第三期乳癌病人的效果
High-dose mitoxantrone–vinblastine–cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study
Ann Oncol 16: 1463-1468
...繼續閱讀

1. 在可手術之乳癌病人，術前以 vinorelbine/epirubicin 治療與標準的adriamycin/cyclophosphamide治療之比較
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)
Annals of Oncology 2005 16(9):1435-1441;

2.
Bendamustine 可以使轉移乳癌病人病情無惡化的時間延長
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC.
Anti-Cancer Drugs. 16(8):871-877, September 2005.
...繼續閱讀

Docetaxel and cisplatin combination chemotherapy in metastatic breast cancer patients with previous exposure to anthracyclines
以 docetaxel 與 cisplatin 治療曾接受過 anthracycline 類藥物治療的轉移乳癌病人
The Breast
Volume 14, Issue 4 , August 2005, Pages 304-309


...繼續閱讀